OGT prevents DNA demethylation and suppresses the expression of transposable elements in heterochromatin by restraining TET activity genome-wide
Preprint in bioRxiv (January 2024)
The most recent citing publications are shown below. View all 63 publications that cite this research output on Dimensions.
Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission
Article in Leukemia & Lymphoma (November 2023)
Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study
Article in Annals of Hematology (November 2023)